Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-296-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral route: LD50 > 2000 mg/kg.
Inhalation: LC50 > 1.88 mg/L.
Intraperitoneal route: LD50 > 2000 mg/kg.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- November 1979
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Source study has reliablity 2. Details on the read across are attached in section 13.
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Acute toxicity in rats assessed in limit test at dose of 5000 mg/kg by oral route. Observations were continued for up to 14 days.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 0.5 % in water
- Details on oral exposure:
- Concentration in vehicle: 50 % m/v
Maximum volume applied: 10 ml/kg - Doses:
- 5000 mg/kg
- No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- no
- Details on study design:
- Duration of observation period following administration: 14 days
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- ca. 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None
- Clinical signs:
- other: Brown urine
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LD0 = 5000 mg/kg
LD50 > 5000 mg/kg - Executive summary:
Method:
Test substance was administered to 5/rat/sex by gavage at dose of 5000 mg/kg. Test animals were observed for 14 days after dosing.
Results:
No mortality was recorded, thus LD0 = 5000 mg/kg and LD50 > 5000 mg/kg.
- Endpoint:
- acute toxicity: oral
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- April 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Source study has reliablity 2. Details on the read across are attached in section 13.
- Principles of method if other than guideline:
- Acute toxicity in rats assessed in a limit test at dose of 2000 mg/kg by oral route. Observations were continued for up to 14 days.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Bantin and Kingman Ltd.
- Weight at study initiation: 195 - 300 g.
- Fasting period before study: 18 - 20 h before treatment.
- Housing: in groups of 5 by sex.
- Diet: ad libitum.
- Water: ad libitum.
- Acclimation period: 3 days.
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3°C
- Humidity: 50 ± 10%
- Photoperiod: natural lighting conditions. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 2000 mg/kg bw based on the individual fasted body weight of the animals at the time of treatment.
- No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days.
- Frequency of observations and weighing: observations for overt toxicity and mortality at 15 min, 1, 2 and 4 hours after treatment and subsequently once daily for 14 days; body weights of survivors at 7 and 14 days after treatment. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- ca. 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None
- Clinical signs:
- other: No signs of overt toxicity.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LD0 = 2000 mg/kg
LD50 > 2000 mg/kg - Executive summary:
Method:
Test substance was administered to 5/rat/sex by gavage at dose of 2000 mg/kg. Test animals were observed for 14 days after dosing.
Results:
No mortality was recorded, thus LD0 = 2000 mg/kg and LD50 > 2000 mg/kg.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- June 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Source study has reliablity 2. Details on the read across are attached in section 13.
- Principles of method if other than guideline:
- Test group (10/rat/sex): a single maximum concentration of test substance as a dust by inhalation (nose only) over a period of 4 hours.
Control group (5/rat/sex): atmosphere of filtered air under similar conditions as test group. - GLP compliance:
- no
- Test type:
- fixed concentration procedure
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories.
- Age at study initiation: aged 7 - 8 weeks.
- Weight at study initiation: 180 - 200 g.
- Housing: group of 5 by sex.
- Diet: ad libitum except during exposure period.
- Water: ad libitum except during exposure period.
- Acclimation period: 15 days.
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3°C.
- Humidity: 50 ± 10%.
- Air changes: 8 -10 air changes per hour.
- Photoperiod: controlled lighting conditions. - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: dried air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Timbrell dust generator.
- Exposure chamber volume: 7 litres capacity.
- Flow rate: 10 l/min.
TEST ATMOSPHERE: mean particle size of the respirable fraction of the atmosphere generated was 1.83 µm. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- gravimetric analysis
- Duration of exposure:
- 4 h
- Concentrations:
- 1.88 mg/l (gravimetric analysis)
43.8 mg/l (nominal concentration) - No. of animals per sex per dose:
- test group: 10/sex
control group: 5/sex - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days.
- Frequency of observations: daily.
- Frequency of weighing: 1 day before exposure and on day 1, 2, 4,8, 11 and 15 after exposure.
- Necropsy of survivors performed: yes, if no deaths accurred during exposure, 1 male and 1 female from each group were killed and subjected to gross necropsy. - Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 1.88 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- ca. 1.88 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No deaths occurred during exposure or during the observation period as a result of exposure to test substance. One female treated rat suffocated as a result of turning around in the restraining tube. A planned sacrifice was made of 1 male treated rat, 1 male control and 1 female control rat after exposure to assess the degree of primary lung irritation.
- Clinical signs:
- other: Male and female animals reacted in the same way to the dust. All animals developed chromodacryorrhoea during exposure for a few hours post exposure. The respiration was shallow after exposure but returned to normal an the day after exposure.
- Body weight:
- The mean body weights of the male and female control rats rose throughout the experiment, slowly until day 2 but thereafter more rapidly. The mean body weight of the treated rats was depressed following exposure but rose steadily during the observation period.
- Gross pathology:
- All control rats and the majority of the treated rats sacrificed after the observation period showed a moderate degree of pulmonary congestion, and pulmonary oedema was noted in some control rats. The female rat which died during exposure and the male rat which was sacrificed immediately after exposure showed only slight pulmonary congestion. No lesions were seen in the other major organs examined.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LC50 > 1.88 mg/l after a 4-hour exposure.
- Executive summary:
Method:
A single maximum concentration of test substance was given to 20 rats (10 male, 10 female) as a dust by inhalation (nose only) over a period of 4 hours. A further 10 rats (5 male, 5 female) were exposed under similar conditions to an atmosphere of filtered air. The concentration of test substance measured by gravimetric analysis was 1.88 mg/L.
Aerodynamic mass median diameter of dust particles was 1.83 µm.
Results:
No substance-related deaths occurred during exposure nor in the following observation period.
All treated animals showed the following signs for 1 -2 days post exposure: chromodacryorrhoea, shallow respiration, discoloured faeces, stained and ruffled fur.
The animals remained alert and their pelts remained stained throughout the observation period. The control animals had chromodacryorrhoea and nasal secretion on the exposure day only. The pelts remained ruffled throughout the observation period.
Mean body weights of male and female control rats rose throughout the experiment, slowly until day 2 but thereafter more rapidly.
The mean body weight of the treated rats was depressed following exposure but rose steadily during the observation period.
Pulmonary congestion was noted in all the control animais. In the treatment group there was a slight to moderate degree of pulmonary congestion in the rats, which were sacrificed at the end of the 14-day observation period.
Reference
Atmosphere control:
The heterogeneous nature of the article did not facilitate the generation of an atmosphere with a uniformly small particle size. lt is believed that the apparent low percentage transfer of dust from the generator to the sample orifice on the side of the exposure chamber was due to:
(i) Deposition of the larger particles on the generator transfer pipe
(ii) Production of a heterogeneous atmosphere in the exposure chamber. Observation of the floor of the exposure chamber after exposure showed a higher deposit of dust in the centre. Consequently the atmosphere probably had a higher concentration of aerodynamically less stable, larger particles in the centre. Therefore, samples drawn from the side of the chamber did not contain a representative fraction of all particles produced, but only those which were available to the animals.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), substances can be allocated to one of four toxicity categories based on acute toxicity by oral, dermal or inhalation route according to numeric criteria. Acute toxicity values are expressed as LD50 (oral, dermal) or LC50 (inhalation) values as well as acute toxicity estimates (ATE).
Oral LD50 above 2000 mg/kg bw was found, thus target substance was not classified for acute oral toxicity in the CLP Regulation (EC 1272/2008).
During the Acute inhalation toxicity test, no mortality was observed at the highest tested concentration. No classification is warranted according the CLP Regulation (EC 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.